The “modest” improvement in progression-free survival means that atezolizumab is “certainly reasonable” as a first-line therapy in metastatic patients, says Cesar Santa-Maria, Northwestern University.
Sunday, 15 September, 2024 | 13:00 – 14:30 CEST BURGOS AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Sunday, 15 September, 2024 | 13:00 – 14:30 CEST BURGOS AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Friday, December 6, 2024 3:30 pm – 5:00 pm PT Room: Grand Ballroom 8-9 Marriott Marquis SD | San Diego, California CME/CNE/CPE Hybrid Join a…
Sunday, 15 September, 2024 | 13:00 – 14:30 CEST BURGOS AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Join Medscape Oncology for a live interactive social media event on themultidisciplinary care for patients with endometrial cancer. Our multidisciplinarypane…
